449 related articles for article (PubMed ID: 15671269)
1. Inhibitory effect of rapamycin on corneal neovascularization in vitro and in vivo.
Kwon YS; Hong HS; Kim JC; Shin JS; Son Y
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):454-60. PubMed ID: 15671269
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of curcumin on corneal neovascularization in vitro and in vivo.
Bian F; Zhang MC; Zhu Y
Ophthalmologica; 2008; 222(3):178-86. PubMed ID: 18497527
[TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
Ma X; Ottino P; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
[TBL] [Abstract][Full Text] [Related]
4. [Inhibition of growth and metastasis of hepatocellular carcinoma by rapamycin: experiment with mice].
Wang Z; Fan J; Zhou J; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1666-70. PubMed ID: 16854316
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of canstatin in alkali burn-induced corneal neovascularization.
Wang Y; Yin H; Chen P; Xie L; Wang Y
Ophthalmic Res; 2011; 46(2):66-72. PubMed ID: 21242701
[TBL] [Abstract][Full Text] [Related]
6. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
You JJ; Yang CH; Huang JS; Chen MS; Yang CM
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
[TBL] [Abstract][Full Text] [Related]
7. Endogenous TNFalpha suppression of neovascularization in corneal stroma in mice.
Fujita S; Saika S; Kao WW; Fujita K; Miyamoto T; Ikeda K; Nakajima Y; Ohnishi Y
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3051-5. PubMed ID: 17591872
[TBL] [Abstract][Full Text] [Related]
8. Chemical injury-induced corneal opacity and neovascularization reduced by rapamycin via TGF-β1/ERK pathways regulation.
Shin YJ; Hyon JY; Choi WS; Yi K; Chung ES; Chung TY; Wee WR
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4452-8. PubMed ID: 23716625
[TBL] [Abstract][Full Text] [Related]
9. A siRNA targeting vascular endothelial growth factor-A inhibiting experimental corneal neovascularization.
Zuo L; Fan Y; Wang F; Gu Q; Xu X
Curr Eye Res; 2010 May; 35(5):375-84. PubMed ID: 20450250
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the pro-angiogenic microenvironment by carboxyamido-triazole.
Oliver VK; Patton AM; Desai S; Lorang D; Libutti SK; Kohn EC
J Cell Physiol; 2003 Oct; 197(1):139-48. PubMed ID: 12942550
[TBL] [Abstract][Full Text] [Related]
11. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha.
Xia XB; Xiong SQ; Xu HZ; Jiang J; Li Y
Curr Eye Res; 2008 Oct; 33(10):892-902. PubMed ID: 18853324
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.
Zhang Z; Ma JX; Gao G; Li C; Luo L; Zhang M; Yang W; Jiang A; Kuang W; Xu L; Chen J; Liu Z
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4062-71. PubMed ID: 16249481
[TBL] [Abstract][Full Text] [Related]
13. Potential anti-angiogenic role of Slit2 in corneal neovascularization.
Han X; Zhang MC
Exp Eye Res; 2010 Jun; 90(6):742-9. PubMed ID: 20298689
[TBL] [Abstract][Full Text] [Related]
14. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.
Lane HA; Wood JM; McSheehy PM; Allegrini PR; Boulay A; Brueggen J; Littlewood-Evans A; Maira SM; Martiny-Baron G; Schnell CR; Sini P; O'Reilly T
Clin Cancer Res; 2009 Mar; 15(5):1612-22. PubMed ID: 19223496
[TBL] [Abstract][Full Text] [Related]
15. Analysis of angiogenesis induced by cultured corneal and oral mucosal epithelial cell sheets in vitro.
Kanayama S; Nishida K; Yamato M; Hayashi R; Sugiyama H; Soma T; Maeda N; Okano T; Tano Y
Exp Eye Res; 2007 Dec; 85(6):772-81. PubMed ID: 17904552
[TBL] [Abstract][Full Text] [Related]
16. Expression of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in corneal lymphangiogenesis.
Mimura T; Amano S; Usui T; Kaji Y; Oshika T; Ishii Y
Exp Eye Res; 2001 Jan; 72(1):71-8. PubMed ID: 11133184
[TBL] [Abstract][Full Text] [Related]
17. Emodin suppression of ocular surface inflammatory reaction.
Kitano A; Saika S; Yamanaka O; Ikeda K; Okada Y; Shirai K; Reinach PS
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5013-22. PubMed ID: 17962452
[TBL] [Abstract][Full Text] [Related]
18. A natural anti-inflammatory enone fatty acid inhibits angiogenesis by attenuating nuclear factor-κB signaling in vascular endothelial cells.
Furuno A; Watari K; Nakamura M; Fukunaga Y; Jung JH; Ono M
Int J Oncol; 2011 Feb; 38(2):493-501. PubMed ID: 21132269
[TBL] [Abstract][Full Text] [Related]
19. Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma.
Wang Z; Zhou J; Fan J; Qiu SJ; Yu Y; Huang XW; Tang ZY
Clin Cancer Res; 2008 Aug; 14(16):5124-30. PubMed ID: 18698030
[TBL] [Abstract][Full Text] [Related]
20. Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea.
Edelman JL; Castro MR; Wen Y
Invest Ophthalmol Vis Sci; 1999 May; 40(6):1112-23. PubMed ID: 10235544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]